Presentation | February 8, 2024

Mabion: Your Biologics CDMO

Source: Mabion
GettyImages-1256323645 drug testing

Mabion, a biopharmaceutical company with 17 years of experience, has established itself as a leading provider of biologic drugs and contract development and manufacturing organization (CDMO) services. With a wide range of offerings, including bioanalytical capabilities, sterile manufacturing, packaging, and serialization, Mabion ensures that its services meet all regulatory requirements through its approved Quality Management System.

The company's facility in Konstantynów Łódzki, Poland, is GMP and ISO-certified and is involved in manufacturing clinical and commercial products. They also provide development processes and analytical methods. The facility offers analytical and quality control services for GMP and non-GMP product testing, including Cell-Based Assays. With a strong focus on regulatory compliance, the facility in Łódź, Poland, is GLP-certified and specializes in bioanalytical studies such as PK, PD, and Immunogenicity. They also have BSL-II labs. Additionally, the facility in Warsaw provides support for clinical trials, including design and operational support.

As a reliable and quality-driven CDMO, Mabion has received certifications in GMP, GLP, GCP, and ISO standards, ensuring that its manufacturing processes meet the required quality standards. The company consistently strives for quality improvement through internal and external audits.

Learn more about Mabion's capabilities as a CDMO, its commitment to quality and customer satisfaction, and the crucial role the company plays in the drug development and manufacturing space by accessing the presentation below.

access the Presentation!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Bioprocess Online